Literature DB >> 30858210

Analysis of the Pseudomonas aeruginosa Aminoglycoside Differential Resistomes Allows Defining Genes Simultaneously Involved in Intrinsic Antibiotic Resistance and Virulence.

Fernando Sanz-García1, Carolina Alvarez-Ortega1, Jorge Olivares-Pacheco1, Paula Blanco1, José Luis Martínez2, Sara Hernando-Amado2.   

Abstract

High-throughput screening of transposon insertion libraries is a useful strategy for unveiling bacterial genes whose inactivation results in an altered susceptibility to antibiotics. A potential drawback of these studies is they are usually based on just one model antibiotic for each structural family, under the assumption that the results can be extrapolated to all members of said family. To determine if this simplification is appropriate, we have analyzed the susceptibility of mutants of Pseudomonas aeruginosa to four aminoglycosides. Our results indicate that each mutation produces different effects on susceptibility to the tested aminoglycosides, with only two mutants showing similar changes in the susceptibility to all studied aminoglycosides. This indicates that the role of a particular gene in the resistome of a given antibiotic should not be generalized to other members of the same structural family. Five aminoglycoside-hypersusceptible mutants inactivating glnD, hflK, PA2798, PA3016, and hpf were chosen for further analysis in order to elucidate if lower aminoglycoside susceptibility correlates with cross-hypersusceptibility to other antibiotics and with impaired virulence. Our results indicate that glnD inactivation leads to increased cross-susceptibility to different antibiotics. The mutant in this gene is strongly impaired in virulence traits such as pyocyanin production, biofilm formation, elastase activity, and swarming motility and the ability to kill Caenorhabditis elegans Thus, GlnD might be an interesting target for developing antibiotic coadjuvants with antiresistance and antivirulence properties against P. aeruginosa.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  Pseudomonas aeruginosazzm321990; adjuvants; intrinsic resistome; virulence

Mesh:

Substances:

Year:  2019        PMID: 30858210      PMCID: PMC6496088          DOI: 10.1128/AAC.00185-19

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  48 in total

1.  Genes involved in intrinsic antibiotic resistance of Acinetobacter baylyi.

Authors:  Maria J Gomez; Alexander A Neyfakh
Journal:  Antimicrob Agents Chemother       Date:  2006-08-28       Impact factor: 5.191

Review 2.  What is a resistance gene? Ranking risk in resistomes.

Authors:  José L Martínez; Teresa M Coque; Fernando Baquero
Journal:  Nat Rev Microbiol       Date:  2014-12-15       Impact factor: 60.633

3.  Membrane proteases and aminoglycoside antibiotic resistance.

Authors:  Aaron Hinz; Samuel Lee; Kyle Jacoby; Colin Manoil
Journal:  J Bacteriol       Date:  2011-07-15       Impact factor: 3.490

4.  Molecular Epidemiology of Mutations in Antimicrobial Resistance Loci of Pseudomonas aeruginosa Isolates from Airways of Cystic Fibrosis Patients.

Authors:  Leonie Greipel; Sebastian Fischer; Jens Klockgether; Marie Dorda; Samira Mielke; Lutz Wiehlmann; Nina Cramer; Burkhard Tümmler
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

Review 5.  Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.

Authors:  R Cantón; N Cobos; J de Gracia; F Baquero; J Honorato; S Gartner; A Alvarez; A Salcedo; A Oliver; E García-Quetglas
Journal:  Clin Microbiol Infect       Date:  2005-09       Impact factor: 8.067

6.  Determinants of intrinsic aminoglycoside resistance in Pseudomonas aeruginosa.

Authors:  Thomas Krahn; Christie Gilmour; Justin Tilak; Sebastien Fraud; Nicholas Kerr; Calvin Ho-Fung Lau; Keith Poole
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

7.  Targeting a bacterial stress response to enhance antibiotic action.

Authors:  Samuel Lee; Aaron Hinz; Elizabeth Bauerle; Angus Angermeyer; Katy Juhaszova; Yukihiro Kaneko; Pradeep K Singh; Colin Manoil
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-12       Impact factor: 11.205

8.  Incidence and risk factors for multiple antibiotic-resistant Pseudomonas aeruginosa in cystic fibrosis.

Authors:  Christian A Merlo; Michael P Boyle; Marie Diener-West; Bruce C Marshall; Christopher H Goss; Noah Lechtzin
Journal:  Chest       Date:  2007-07-23       Impact factor: 9.410

9.  Identification of a small molecule that simultaneously suppresses virulence and antibiotic resistance of Pseudomonas aeruginosa.

Authors:  Qiaoyun Guo; Yu Wei; Bin Xia; Yongxin Jin; Chang Liu; Xiaolei Pan; Jing Shi; Feng Zhu; Jinlong Li; Lei Qian; Xinqi Liu; Zhihui Cheng; Shouguang Jin; Jianping Lin; Weihui Wu
Journal:  Sci Rep       Date:  2016-01-11       Impact factor: 4.379

Review 10.  The arsenal of pathogens and antivirulence therapeutic strategies for disarming them.

Authors:  John R Brannon; Maria Hadjifrangiskou
Journal:  Drug Des Devel Ther       Date:  2016-05-27       Impact factor: 4.162

View more
  2 in total

1.  A wide-ranging Pseudomonas aeruginosa PeptideAtlas build: A useful proteomic resource for a versatile pathogen.

Authors:  J A Reales-Calderón; Z Sun; V Mascaraque; E Pérez-Navarro; V Vialás; E W Deutsch; R L Moritz; C Gil; J L Martínez; G Molero
Journal:  J Proteomics       Date:  2021-03-20       Impact factor: 4.044

2.  Role of the multi-drug efflux systems on the baseline susceptibility to ceftazidime/avibactam and ceftolozane/tazobactam in clinical isolates of non-carbapenemase-producing carbapenem-resistant Pseudomonas aeruginosa.

Authors:  María José Contreras-Gómez; José R W Martinez; Lina Rivas; Roberto Riquelme-Neira; Juan A Ugalde; Aniela Wozniak; Patricia García; José M Munita; Jorge Olivares-Pacheco; Manuel Alcalde-Rico
Journal:  Front Pharmacol       Date:  2022-10-03       Impact factor: 5.988

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.